Matt Gersper

Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ.

Vanguard Health Systems, Inc. engages in the provision of hospital and health care services. It specializes in metropolitan hospital development, health and wellness, patient experience, and employee engagement. The company was founded by Charles N. Martin, Jr., Ronald P. Soltman, William Lawrence Hough and Joseph D. Moore on July 1, 1997 and is headquartered in Nashville, TN.

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

HandyLab, Inc. develops and manufactures novel clinical diagnostic testing products. It serves medical, industrial and bio-defense markets. The company was founded by Kalyan Handique and Sundaresh Brahmasandra in 2000 and is headquartered in Plymouth, MI.

Avisa Pharma, Inc. engages in the development of drug and device novel biomarker technology platform which enables the rapid detection of virulent bacterial pathogens within minutes. The company was founded by David Samuel Joseph in 2010 and is headquartered in Santa Fe, NM.

Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN.

Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN.

Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands.

Phenomix Sciences, Inc. develops data-driven precision medicine that individualizes obesity treatment. The company is based in Menlo Park, CA. The company was founded by Andres Acosta and Michael Camilleri. The CEO is Mark N. K. Bagnall.